Gestational Diabetes Mellitus, Screening
Release Date: January 2014
Summary of Recommendations and Evidence
|Asymptomatic Pregnant Women, After 24 Weeks of Gestation|
The USPSTF recommends screening for gestational diabetes mellitus (GDM) in asymptomatic pregnant women after 24 weeks of gestation.
|The USPSTF recommends the service. There is high certainty that the net benefit is moderate or there is moderate certainty that the net benefit is moderate to substantial.|
|Asymptomatic Pregnant Women, Before 24 Weeks of Gestation|
The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for GDM in asymptomatic pregnant women before 24 weeks of gestation.
|The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of the service. Evidence is lacking, of poor quality, or conflicting, and the balance of benefits and harms cannot be determined.|
- Beneﬁts and Harms of Treating Gestational Diabetes Mellitus: A Systematic Review and Meta-analysis for the U.S. Preventive Services Task Force and the National Institutes of Health Ofﬁce of Medical Applications of Research
- Screening Tests for Gestational Diabetes: A Systematic Review for the U.S. Preventive Services Task Force
Internet Citation: Recommendation Summary. U.S. Preventive Services Task Force. September 2014.